Problem is that not too many have confidence in the timeframes indicated by Select's announcements.
But when Hep A is done - think about it - 10 x the revenue of Hep E. No longer do we get only 65% of the pie. Then, a working Hep C kit, with Chiron Manager on Select's board of directors.
When the above is confirmed to the market, this stock could easily be over $1.50.
In my opinion the reason for the discounted share price is for lack of confidence in timeframes.
We are only weeks away now from the expected target dates...
SLT Price at posting:
0.0¢ Sentiment: ST Buy Disclosure: Held
